Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06283667
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-07-03
First Post:
2024-02-21
Brief Title:
Special Use - Results Surveillance on Long-term Use With Wegovy
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
A Multi-centre Prospective Non-interventional Single-armed 104 Weeks Post-marketing Study to Investigate Safety and Clinical Parameters of Wegovy Once Weekly in Patients With Obesity Disease Under Real-world Clinical Practice Conditions
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to investigate the safety and effectiveness of Wegovy in patients with obesity disease under real-world clinical practice in Japan Participants will get Wegovy as prescribed by the study doctor The study will last for about 4 years Participant will be in the study for about 2 years 104 weeks
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U1111-1266-3863 | OTHER | World Health Organization WHO | None |